HTFL insider transaction filings
Heartflow, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen HTFL transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 32,676 @ $45 | EDGAR |
| 2026-08-19 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 9,219 @ $19 · Sale (S): 9,219 @ $41.23 · Option exercise (M): 9,219 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 15,560 @ $39.06 | EDGAR |
| 2026-08-12 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 22,562 @ $28.31 | EDGAR |
| 2026-08-10 | 4 | Jones Marie L. — Chief Accounting Officer | Grant/award (A): 1,661 @ $16.15 · Tax withholding (F): 486 @ $27.19 · Tax withholding (F): 82 @ $28.82 | EDGAR |
| 2026-08-10 | 4 | Verghese Vikram — Chief Financial Officer | Grant/award (A): 671 @ $16.15 · Tax withholding (F): 1,537 @ $27.19 · Tax withholding (F): 473 @ $28.82 | EDGAR |
| 2026-08-10 | 4 | Rogers Campbell — Chief Medical Officer | Tax withholding (F): 1,635 @ $27.19 · Tax withholding (F): 637 @ $28.82 | EDGAR |
| 2026-08-10 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Tax withholding (F): 5,847 @ $27.19 · Tax withholding (F): 1,904 @ $28.82 | EDGAR |
| 2026-07-31 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Option exercise (M): 2,789 @ $8.33 · Option exercise (M): 18,694 @ $2.22 · Option exercise (M): 9,737 @ $9.58 · Option exercise (M): 18,694 (derivative) @ $0 · Option exercise (M): 2,789 (derivative) @ $0 · Option exercise (M): 9,737 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Verghese Vikram — Chief Financial Officer | Option exercise (M): 22,522 @ $2.22 · Option exercise (M): 22,522 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Lightcap Jeffrey C — Director | Option exercise (M): 47,420 @ $19 · Option exercise (M): 47,420 (derivative) @ $0 | EDGAR |
| 2026-07-24 | 4 | BARABE TIMOTHY C — Director | Option exercise (M): 3,710 @ $19 · Option exercise (M): 3,710 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Verghese Vikram — Chief Financial Officer | Option exercise (M): 22,522 @ $2.22 · Option exercise (M): 22,522 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | BARABE TIMOTHY C — Director | Option exercise (M): 5,000 @ $19 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 9,219 @ $19 · Sale (S): 9,219 @ $25.72 · Option exercise (M): 9,219 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 22,562 @ $27.75 | EDGAR |
| 2026-07-10 | 4 | WELDON WILLIAM C — Director | Option exercise (M): 17,123 @ $8.33 · Option exercise (M): 17,123 @ $8.33 · Option exercise (M): 17,123 @ $8.33 · Option exercise (M): 17,123 (derivative) @ $0 · Option exercise (M): 17,123 (derivative) @ $0 · Option exercise (M): 17,123 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 38,900 @ $35 | EDGAR |
| 2026-06-18 | 4 | Cullivan Julie A — Director | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-06-18 | 4 | Lightcap Jeffrey C — Director | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-06-18 | 4 | Tansey Casey M — Director | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-06-18 | 4 | Riley Wayne Joseph — Director | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-06-18 | 4 | BARABE TIMOTHY C — Director | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-06-18 | 4 | WELDON WILLIAM C — Director | Grant/award (A): 16,075 (derivative) @ $32.05 | EDGAR |
| 2026-06-17 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 10,000 @ $2.22 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 22,562 @ $28.50 | EDGAR |
| 2026-05-20 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 9,219 @ $19 · Sale (S): 9,219 @ $28.34 · Option exercise (M): 9,219 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 22,562 @ $29.12 | EDGAR |
| 2026-05-08 | 4 | Jones Marie L. — Chief Accounting Officer | Tax withholding (F): 485 @ $30.29 · Tax withholding (F): 82 @ $29.98 | EDGAR |
| 2026-05-08 | 4 | Rogers Campbell — Chief Medical Officer | Tax withholding (F): 1,634 @ $30.29 · Tax withholding (F): 637 @ $29.98 | EDGAR |
| 2026-05-08 | 4 | Verghese Vikram — Chief Financial Officer | Tax withholding (F): 1,536 @ $30.29 · Tax withholding (F): 473 @ $29.98 | EDGAR |
| 2026-05-08 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Tax withholding (F): 5,300 @ $30.29 · Tax withholding (F): 1,904 @ $29.98 | EDGAR |
| 2026-04-30 | 4 | Bain Capital Life Sciences Investors, LLC — 10% owner Bain Capital Life Sciences III General Partner, LLC — 10% owner Bain Capital Life Sciences Fund III, L.P. — 10% owner BCLS Fund III Investments GP, LLC — 10% owner BCLS Fund III Investments, LP — 10% owner | Sale (S): 254,110 @ $30.51 · Sale (S): 797,133 @ $29.37 · Sale (S): 892,533 @ $29.18 · Sale (S): 56,224 @ $30.05 | EDGAR |
| 2026-04-14 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 22,562 @ $26.72 | EDGAR |
| 2026-04-03 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 291 @ $8.33 · Option exercise (M): 19,111 @ $2.22 · Option exercise (M): 40,766 @ $2.22 · Option exercise (M): 6,849 @ $2.22 · Sale (S): 64,533 @ $24.64 · Option exercise (M): 6,849 (derivative) @ $0 · +3 more | EDGAR |
| 2026-03-26 | 4 | HealthCor Partners Management LP — Director | Other (J): 4,615,542 | EDGAR |
| 2026-03-26 | 4 | Lightcap Jeffrey C — Director | Other (J): 206,261 @ $0 | EDGAR |
| 2026-03-23 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 19,402 @ $2.22 · Option exercise (M): 47,615 @ $2.22 · Sale (S): 64,533 @ $25.69 · Option exercise (M): 19,402 (derivative) @ $0 · Option exercise (M): 47,615 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Sale (S): 9,725 @ $25 | EDGAR |
| 2026-03-12 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Grant/award (A): 2,631 @ $16.15 · Sale (S): 12,837 @ $22.66 | EDGAR |
| 2026-03-12 | 4 | BARABE TIMOTHY C — Director | Option exercise (M): 8,667 @ $2.22 · Option exercise (M): 8,667 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Cullivan Julie A — Director | Sale (S): 9,122 @ $25 | EDGAR |
| 2026-02-19 | 4 | BARABE TIMOTHY C — Director | Option exercise (M): 2,497 @ $8.33 · Option exercise (M): 2,497 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Rogers Campbell — Chief Medical Officer | Option exercise (M): 19,401 @ $2.22 · Option exercise (M): 39,709 @ $8.33 · Option exercise (M): 7,906 @ $2.22 · Sale (S): 65,153 @ $24.49 · Option exercise (M): 39,709 (derivative) @ $0 · Option exercise (M): 19,401 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-10 | 4 | Jones Marie L. — Chief Accounting Officer, VP | Tax withholding (F): 94 @ $27.74 · Grant/award (A): 21,629 @ $0 · Grant/award (A): 37,795 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Farquhar John C.M. — Chief Executive Officer, Director | Tax withholding (F): 1,541 @ $27.74 · Grant/award (A): 183,850 @ $0 · Sale (S): 22,562 @ $27.46 · Grant/award (A): 321,259 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Rogers Campbell — Chief Medical Officer | Tax withholding (F): 515 @ $27.74 · Grant/award (A): 54,073 @ $0 · Grant/award (A): 94,488 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Verghese Vikram — Chief Financial Officer | Tax withholding (F): 542 @ $27.74 · Grant/award (A): 68,493 @ $0 · Grant/award (A): 119,685 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Cullivan Julie A — Director | Sale (S): 8,000 @ $27.32 | EDGAR |
| 2026-02-06 | 4 | Bain Capital Life Sciences Investors, LLC — 10% owner Bain Capital Life Sciences III General Partner, LLC — 10% owner Bain Capital Life Sciences Fund III, L.P. — 10% owner BCLS Fund III Investments GP, LLC — 10% owner BCLS Fund III Investments, LP — 10% owner | Sale (S): 2,000,000 @ $28.05 | EDGAR |
Recent 8-K events — Heartflow, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure | EDGAR |
| 2025-08-25 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-08-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HTFL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →